In January 2021, "NeuroEchos", an innovative medical device of functional neurosurgery and intelligent diagnostic service provider, announced the completion of the 30 Million of Yuan pre-A round financing. This round of financing was jointly invested by ASB Ventures and YuanBio Venture Capital, old shareholders followed the investment.
NeuroEchos was established in August 2017, focusing on the field of functional neurosurgery. It uses precise EEG as the breakthrough to provide an integrated diagnosis and treatment combining software and hardware for a variety of neurological diseases of the nervous system. So far, NeuroEchos has completed the first generation of 3.0T magnetic resonance orientated SEEG electrodes, accelerating the advancement of clinical trials and the AI-assisted intelligent detection system for epilepsy waves based on NeuroEchos' independent core algorithm. NeuroEchos also accelerates the second generation of Macro-Micro radiofrequency ablation SEEG electrodes development and clinical trials.
Llinks, as the legal counsel to this financing round of NeuroEcho, provided professional legal services with its rich project experience in the field of investment and financing.
